Showing results (161-170 of 234) with videos related to

Sort By:
Pageof 24
Plos One|November 5, 2011
The FSHD atrophic myotube phenotype is caused by DUX4 expressionCéline Vanderplanck, Eugénie Ansseau, Sébastien Charron, et al.
Neuromuscular Disorders : NMD|August 22, 2006
Induced dystrophin exon skipping in human muscle explantsG McClorey, A M Fall, H M Moulton, et al.
Cellular and Molecular Life Sciences : CMLS|September 11, 2020
NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastomaAlina Naveed, Jack A Cooper, Ruohan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancerF V Fossella, J S Lee, W K Murphy, et al.
Muscle & Nerve|July 9, 1998
Alternative dystrophin gene transcripts in golden retriever muscular dystrophyS J Schatzberg, L V Anderson, S D Wilton, et al.
Scientific Reports|November 13, 2023
Induced alternative splicing an opportunity to study PCSK9 protein isoforms at physiologically relevant concentrationsJessica M Cale, Kristin A Ham, Dunhui Li, et al.
International Journal of Experimental Pathology|November 12, 2013
Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouseYue-Bei Luo, Russell D Johnsen, Lisa Griffiths, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trialT D Brisbois, I H de Kock, S M Watanabe, et al.
Pageof 24